COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

Completed · Phase 3

Conditions studied: Arthritis, Rheumatoid

In brief

This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis.

Key facts

Study ID

NCT00113308

Run by

GlaxoSmithKline

People needed

2208

Starts

2005-06-01

Expected to finish

2006-09-01

Last updated by the study team

2017-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Rheumatoid arthritis (RA) for at least 12 months.
• Required a non-steroidal anti-inflammatory drug (NSAID) or COX-2 inhibitor for RA for at least 5 out of 7 days of each week for the 4 weeks prior to screening.

You may not qualify if…

• Any history of cardiovascular disease (e.g., heart attack, stroke, congestive heart failure, uncontrolled high blood pressure), documented peripheral arterial insufficiency and symptomatic, clinically significant claudication, or who have a history of peripheral arterial embolism.
• Have an active stomach ulcer or history of any stomach tear or bleeding.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Huntsville, Alabama, United States
• GSK Investigational Site — Montgomery, Alabama, United States
• GSK Investigational Site — Montgomery, Alabama, United States
• GSK Investigational Site — Glendale, Arizona, United States
• GSK Investigational Site — Scottsdale, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Anaheim, California, United States
• GSK Investigational Site — Palm Desert, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Santa Monica, California, United States
• GSK Investigational Site — Upland, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Bridgeport, Connecticut, United States
• GSK Investigational Site — Danbury, Connecticut, United States
• GSK Investigational Site — Hamden, Connecticut, United States
• GSK Investigational Site — Trumbull, Connecticut, United States
• GSK Investigational Site — Aventura, Florida, United States
• GSK Investigational Site — Daytona Beach, Florida, United States
• GSK Investigational Site — DeLand, Florida, United States
• GSK Investigational Site — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.